Wang Y - Search Results

1

MiR-125b regulates epithelial-mesenchymal transition via targeting Sema4C in paclitaxel-resistant breast cancer cells.

Yang Q, Wang Y, Lu X, Zhao Z, Zhu L, Chen S, Wu Q, Chen C, Wang Z. Yang Q, et al. Among authors: wang z, wang y. Oncotarget. 2015 Feb 20;6(5):3268-79. doi: 10.18632/oncotarget.3065. Oncotarget. 2015. PMID: 25605244 Free PMC article.

2

Blocking the formation of radiation-induced breast cancer stem cells.

Wang Y, Li W, Patel SS, Cong J, Zhang N, Sabbatino F, Liu X, Qi Y, Huang P, Lee H, Taghian A, Li JJ, DeLeo AB, Ferrone S, Epperly MW, Ferrone CR, Ly A, Brachtel EF, Wang X. Wang Y, et al. Among authors: wang x. Oncotarget. 2014 Jun 15;5(11):3743-55. doi: 10.18632/oncotarget.1992. Oncotarget. 2014. PMID: 25003837 Free PMC article.

3

MiR-320a inhibits gastric carcinoma by targeting activity in the FoxM1-P27KIP1 axis.

Wang Y, Zeng J, Pan J, Geng X, Li L, Wu J, Song P, Wang Y, Liu J, Wang L. Wang Y, et al. Among authors: wang l. Oncotarget. 2016 May 17;7(20):29275-86. doi: 10.18632/oncotarget.8676. Oncotarget. 2016. PMID: 27086911 Free PMC article.

4

N-peptide of vMIP-Ⅱ reverses paclitaxel-resistance by regulating miRNA-335 in breast cancer.

Wang Y, Wang H, Ding Y, Li Y, Chen S, Zhang L, Wu H, Zhou J, Duan K, Wang W, Chen C, Yang Q. Wang Y, et al. Among authors: wang h, wang w. Int J Oncol. 2017 Sep;51(3):918-930. doi: 10.3892/ijo.2017.4076. Epub 2017 Jul 19. Int J Oncol. 2017. PMID: 28731125

5

Involvement of miR-451 in resistance to paclitaxel by regulating YWHAZ in breast cancer.

Wang W, Zhang L, Wang Y, Ding Y, Chen T, Wang Y, Wang H, Li Y, Duan K, Chen S, Yang Q, Chen C. Wang W, et al. Among authors: wang h, wang y. Cell Death Dis. 2017 Oct 5;8(10):e3071. doi: 10.1038/cddis.2017.460. Cell Death Dis. 2017. PMID: 28981108 Free PMC article.

6

PDGFRα up-regulation mediated by sonic hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation.

Sabbatino F, Wang Y, Wang X, Flaherty KT, Yu L, Pepin D, Scognamiglio G, Pepe S, Kirkwood JM, Cooper ZA, Frederick DT, Wargo JA, Ferrone S, Ferrone CR. Sabbatino F, et al. Among authors: wang x, wang y. Oncotarget. 2014 Apr 15;5(7):1926-41. doi: 10.18632/oncotarget.1878. Oncotarget. 2014. PMID: 24732172 Free PMC article.

7

Critical role of histone demethylase RBP2 in human gastric cancer angiogenesis.

Li L, Wang L, Song P, Geng X, Liang X, Zhou M, Wang Y, Chen C, Jia J, Zeng J. Li L, et al. Among authors: wang l, wang y. Mol Cancer. 2014 Apr 9;13:81. doi: 10.1186/1476-4598-13-81. Mol Cancer. 2014. PMID: 24716659 Free PMC article.

8

The short-term effect of histone deacetylase inhibitors, chidamide and valproic acid, on the NF‑κB pathway in multiple myeloma cells.

Liu Z, Jing Q, Wang Y, Li Y, Mi F, Xiang C, Fu R. Liu Z, et al. Among authors: wang y. Int J Mol Med. 2019 Jan;43(1):285-293. doi: 10.3892/ijmm.2018.3963. Epub 2018 Oct 29. Int J Mol Med. 2019. PMID: 30387821 Free PMC article.

9

High expression of PIM2 induces HSC proliferation in myelodysplastic syndromes via the IDH1/HIF1-α signaling pathway.

Liu Z, Tian M, Ding K, Liu H, Wang Y, Fu R. Liu Z, et al. Among authors: wang y. Oncol Lett. 2019 Jun;17(6):5395-5402. doi: 10.3892/ol.2019.10256. Epub 2019 Apr 16. Oncol Lett. 2019. PMID: 31186757 Free PMC article.

10

Monoclonal antibody-based immunotherapy of ovarian cancer: targeting ovarian cancer cells with the B7-H3-specific mAb 376.96.

Fauci JM, Sabbatino F, Wang Y, Londoño-Joshi AI, Straughn JM Jr, Landen CN, Ferrone S, Buchsbaum DJ. Fauci JM, et al. Among authors: wang y. Gynecol Oncol. 2014 Jan;132(1):203-10. doi: 10.1016/j.ygyno.2013.10.038. Epub 2013 Nov 9. Gynecol Oncol. 2014. PMID: 24216048

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

273,782 results

Search Page